Accelerated TPA for treatment of prosthetic valve thrombosis

Clinical Cardiology

Volumn 19, Issue 8, 1996, Pages 665-668

  Denofrio, David ^a,b,c   Ament, Alan F ^a   Mark, Jonathan B ^a,b   George, Samuel E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

prosthetic valve; thrombolysis; TPA

Indexed keywords

FUROSEMIDE; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; WARFARIN;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FIBRINOLYTIC THERAPY; HEPARINIZATION; HUMAN; INTRACARDIAC THROMBOSIS; INTRAVENOUS DRUG ADMINISTRATION; MALE; MITRAL VALVE PROSTHESIS;

EID: 0029790237     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960190816     Document Type: Article

References (11)

1. Deviri E, Sareli P, Wisenbaugh T, Cronje SL: Obstruction of mechanical heart valve prosthesis: Clinical aspects and surgical management. J Am Coll Cardiol 17, 646-650 (1991)
2. Sandza JG, Clark RE, Ferguson TB, Connors JP, Weldon CS: Replacement of prosthetic heart valves. J Thorac Cardiovasc Surg 74, 864-873 (1977)
3. Kurzrok S, Singh AK, Most AS, Williams DO: Thrombolytic therapy for prosthetic cardiac valve thrombosis. J Am Coll Cardiol 9, 592-598 (1987)
4. Czer LSC, Weiss M, Bateman TM, Pfaff JM, DeRobertis M, Eigler N, Vas R, Matloff JM, Gray RJ: Fibrinolytic therapy of St. Jude valve thrombosis under guidance of digital cinefluoroscopy. J Am Coll Cardiol 5, 1244-1249 (1985)
5. Roudaut R, Labbe T, Lorient-Roudaut MF, Gosse P, Baudet E, Fontan F, Besse P, Dallocchio M: Mechanical cardiac valve thrombosis. Is fibrinolysis justified? Circulation 86(suppl II), II-8-II-15 (1992)
6. Silber H, Khan SS, Matloff JM, Chaux A, DeRobertis M, Gray R: The St. Jude valve: Thrombolysis as the first line of therapy for cardiac valve thrombosis. Circulation 87, 30-37 (1993)
7. Graver LM, Gelber PM, Tyras DH: The risks and benefits of thrombolytic therapy in acute aortic and mitral prosthetic valve dysfunction: Report of a case and review of the literature. Ann Thorac Surg 46, 85-88 (1988)
8. Vitale N, Renzulli A, Cerasuolo F, Caruso A, Festa M, DeLuca L, Cotrufo M: Prosthetic valve obstruction: Thrombolysis versus operation. Ann Thorac Surg 57, 365-370 (1994)
9. Neuhaus KL, Feuerer W, Jeep-Tebbe S, Niederer W, Vogt A, Tebbe U: Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator. J Am Coll Cardiol 14, 1566-1569 (1989)
10. Carney RJ, Murphy GA, Brandt TR, Daley PJ, Pickering E, White HJ, McDonough TJ, Vermily SK, Teichman SL: Randomized angiographic trial of recombinant tissue-type plasminogen activator (alteplase) in myocardial infarction. J Am Coll Cardiol 20, 17-20 (1992)
11. The GUSTO investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329, 673-682 (1993)